Figure 3From: A recombinant scFv-FasLext as a targeting cytotoxic agent against human Jurkat-Ras cancerIncrease of sensitivity of human cancer target cells bearing TAG-72 or TAL6 toward cc49-FasL ext and L6scFv-FasL ext , respectively. The cytotoxicity against A-20 and Jurkat targets were conducted with 5-hour 51Cr release assays. The cytotoxicity against HeLa targets was conducted in 24-hour MTT assays. Please note that x-axis scale of panel C is on a pM scale.Back to article page